Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
#NewsBeep #News #Medication #AU #Australia #clinicaltrial #EliLilly #GLP-1 #Health #Obesity #Ozempic #Retatrutide #WeightLoss
https://www.newsbeep.com/au/915863/